Company CVAbout Bharat Immunological & Biological Corporation Ltd 
Bharat Immunological & Biological Corporation Ltd
Micro Cap
Pharmaceuticals & Drugs
The Bharat Immunologicals and Biologicals Corporation Limited (BIBCOL) is a Central Public Sector Unit, under the Department of Biotechnology, Ministry of Science and Technology. BIBCOL was incorporated in 1989. The Company is engaged in the manufacture of Oral Polio Vaccine (OPV) , Zinc Tablets and Diarehha management Kit and BIB Sweet Tablets. The company's manufacturing unit is located in Bulandshahr Dist., Uttar Pradesh. BIBCL installed a plant of 100 mln units.
Company Coordinates
Company Details
BIBCOL OPV Plant Village Chola , Bulandshahr Uttar Pradesh : 203203
Registrar Details
MAS Services Ltd, T-34 , 2nd Floor, Okhla Industrial Area, Phase - II, New Delhi
Capital StructureCapital Structure
Present Equity Capital
INR 43.18 Cr
Number of Shares
4.32 Cr
Face Value
INR 10.0
Date
Number
of Shares(Cr)
of Shares(Cr)
Equity
Capital (Rs Cr)
Capital (Rs Cr)
Shares Added
Face Value (Rs)
Reason
31-Dec-2007
4.32
43.18
17790000
10
Allotment of Equity To Others
31-Dec-2007
4.32
43.18
17790000
10
Allotment of Equity To Others
ShareholdingShareholding Snapshot
Shareholding Compare (%holding)
Majority shareholders
Promoters
Pledged Promoter Holdings
None
Mutual Funds
Held by 0 Schemes
FIIs
Held by 0 FIIs
Promoter with highest holding
President Of India (59.25%)
Highest Public shareholder
None
Individual Investors Holdings
39.47%
Board of Directors
Management
Designation
Remuneration
Y K Gupta
Chairman & Independent Directo
8.0 k
Sandip K Lal
Company Sec. & Compli. Officer
0
Alka Sharma
Independent Director
0
Mohd Aslam
Independent Director
0
Sudhanshu Vrati
Independent Director
6.0 k
Madhu Dikshit
Independent Director
6.0 k
Sanjay Kumar Mishra
Managing Director
0
Pankaj Kumar
Independent Director
0
Raw MaterialsRaw Materials Dashboard
Raw Materials
Amount(Rs Cr)
% of RM Cost
No Data Available for Raw Material Segmentation
No Data Available
Finished Goods Finished Goods Dashboard
Finished Goods
Amount(Rs Cr)
% of Sales Turnover
Others
45.07
97.13%
Zinc Dispersibe Tablet
0.74
1.60%
Diarrhea Management Combo Kits
0.59
1.27%
Others
Others
Zinc Dispersibe Tablet
Zinc Dispersibe Tablet
Diarrhea Management Combo Kits
Diarrhea Management Combo Kits
Stock DNARevenue and Profits:
Net Sales:
(Quarterly Results - Sep 2023)
Net Profit:
-5 Cr
Pharmaceuticals & Drugs
INR 97 Cr (Micro Cap)
NA (Loss Making)
33
0.00%
0.83
-22.96%
1.21
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
